Viewing Study NCT02429466

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:19 PM
Ignite Modification Date: 2026-03-13 @ 4:00 PM
Study NCT ID: NCT02429466
Status: COMPLETED
Last Update Posted: 2020-09-23
First Post: 2015-04-14
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of the Hypomethylating Drug Guadecitabine (SGI-110) Plus Cisplatin in Relapsed Refractory Germ Cell Tumors
Sponsor: Nasser Hanna
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Germ Cell Tumor View
None Testis Cancer View
None Testicular Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None testicular germ cell tumor View
None ovarian germ cell tumor View
None platinum refractory View
None cisplatin View
None SGI110 View
None Guadecitabine View